Multi-site point of care assessment of Abbott ID NOW rapid molecular test for SARS-CoV-2 in a low-prevalence setting-Reference-Cited by-同舟云学术

Multi-site point of care assessment of Abbott ID NOW rapid molecular test for SARS-CoV-2 in a low-prevalence setting

Published:2021-12 Issue:7 Volume:53 Page:912-914
ISSN:0031-3025
Container-title:Pathology
language:en
Short-container-title:Pathology

Author:

Graham Maryza^ORCID,Muhi Stephen,Hoang Tuyet,Ballard Susan A.,McAuley Julie,Kwong Jason C.,Williamson Deborah A.,Howden Benjamin P.

Publisher

Elsevier BV

Subject

Pathology and Forensic Medicine

Reference12 articles.

1. Modelling transmission and control of the COVID-19 pandemic in Australia;Chang;Nat Commun,2020

2. Impact of delays on effectiveness of contact tracing strategies for COVID-19: a modelling study;Kretzschmar;Lancet Public Health,2020

3. Rethinking COVID-19 test sensitivity - a strategy for containment;Mina;N Engl J Med,2020

4. Test sensitivity is secondary to frequency and turnaround time for COVID-19 surveillance;Larremore;medRxiv,2020

5. Cochrane COVID-19 Diagnostic Test Accuracy Group. Rapid, point-of-care antigen and molecular-based tests for diagnosis of SARS-CoV-2 infection;Dinnes;Cochrane Database Syst Rev,2021

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Recent progress on rapid diagnosis of COVID-19 by point-of-care testing platforms;Chinese Chemical Letters;2024-03

2. The diagnostic accuracy of the ID NOW COVID-19 point of care test in acute hospital admissions;Journal of Clinical Virology;2024-02

3. Point of care molecular and antigen detection tests for COVID-19: current status and future prospects;Expert Review of Molecular Diagnostics;2022-08-03

4. Diagnostic accuracy of the Abbott ID NOW SARS-CoV-2 rapid test for the triage of acute medical admissions;Journal of Hospital Infection;2022-05

5. Avoiding false positive SARS-CoV-2 rapid antigen test results with point-of-care molecular testing on residual test buffer;2022-02-24